Anamorelin Study for Advanced Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Metastatic Pancreatic Cancer
Related studies linked through entity extraction aliases.
Atezolizumab + Cabozantinib in Patients w/ Metastatic, Refractory Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Single Patient Protocol for an NRG1 Fusion Positive Metastatic Pancreatic Cancer Patient Using Seribantumab
- Status
- COMPLETED
- Phase
- PHASE2
Good Choice of pALliative Chemotherapy to Patient With Pancreatic Cancer ; GemcitAbine Therapy vs FOLFORINOX therapY
- Status
- COMPLETED
- Phase
- N/A
Flouro-Gem in Adenocarcinoma of the Pancreas (GEFLUPAN)
- Status
- COMPLETED
- Phase
- PHASE2
Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer.
- Status
- RECRUITING
- Phase
- PHASE2
Anlotinib, Toripalimab and Nab-paclitaxel in Locally Advanced/Metastatic Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Modified FOLFIRINOX Alternated With Biweekly Gemcitabine Plus Nab-Paclitaxel Untreated Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
First-in-human Study of the Theranostic Pair [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G in Pancreatic Cancer
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
PANFIRE-3 Trial: Assessing Safety and Efficacy of Irreversible Electroporation (IRE) + Nivolumab + CpG for Metastatic Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Saltikva for Metastatic Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Efficacy and Safety of Camrelizumab Combined With Nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Niraparib + Dostarlimab + RT in Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Nivolumab + Ipilimumab + Radiation in MSS Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Immune Checkpoint Inhibitor M7824 and the Immunocytokine M9241 in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Advanced Pancreas Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of Maintenance Treatment With Fluzoparib in gBRCA/PALB2 Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy
- Status
- TERMINATED
- Phase
- PHASE3
A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Irreversible Electroporation (IRE) Followed by Nivolumab in Patients With Metastatic Pancreatic Cancer.
- Status
- TERMINATED
- Phase
- PHASE2